Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q3 2018 Earnings

8NovExpected

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-13.5

-9.12

-4.74

-0.36

Details

Expected EPS

-0.44

Actual EPS

-13.5

Surprise EPS

-13.06

Surprise Percent

+2,968.18%

Description

Spyre Therapeutics (SYRE) has reported earnings of -13.5 per share for Q3 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.